45 /100
MEDIUM RISK
Score updated May 30, 2026

PMN — ProMIS Neurosciences, Inc. Dilution Risk Tracker

Track PMN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
47
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
📉 Score Deterioration 40%
• Score rose 21 points recently (worsening)
🔁 Convertible Conversion 15%
• Convertible debt present: 7.1% potential dilution
🔔 Track PMN — Get forecast alerts →

💹 Market Data

Market Cap$96.94M
Shares Outstanding8.97M
Float4.60M
Cash$63.85M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 1.7K shares
#1 BANK OF AMERICA CORP /DE/ 1.7K shares

📉 Short Interest

Short Interest166.6K
Days to Cover4.6
% of Float3.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Jun 30, 2022
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PMN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PMN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for PMN
📊 PMN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PMN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.